Product
Active Dose 2 (100 mg) MDMA
1 clinical trial
1 indication
Indication
Post-Traumatic Stress DisorderClinical trial
A Randomized, Double-Blind, Dose Response Phase 2 Pilot Study of Manualized MDMA-Assisted Psychotherapy in Subjects With Chronic, Treatment-Resistant Posttraumatic Stress Disorder (PTSD)Status: Completed, Estimated PCD: 2015-12-03